Format
Items per page
Sort by

Send to:

Choose Destination

Results: 17

Cited In for PubMed (Select 19307470)

1.

HDL-C, ABCA1-mediated cholesterol efflux, and lipoprotein(a): insights into a potential novel physiologic role of lipoprotein(a).

Yeang C, Tsimikas S.

J Lipid Res. 2015 Jul;56(7):1241-4. doi: 10.1194/jlr.E060947. Epub 2015 May 26. No abstract available.

PMID:
26014961
2.

Heritability of Biomarkers of Oxidized Lipoproteins: Twin Pair Study.

Rao F, Schork AJ, Maihofer AX, Nievergelt CM, Marcovina SM, Miller ER, Witztum JL, O'Connor DT, Tsimikas S.

Arterioscler Thromb Vasc Biol. 2015 Jul;35(7):1704-11. doi: 10.1161/ATVBAHA.115.305306. Epub 2015 May 7.

PMID:
25953646
3.

Lipoprotein (a) upregulates ABCA1 in liver cells via scavenger receptor-B1 through its oxidized phospholipids.

Sharma M, Von Zychlinski-Kleffmann A, Porteous CM, Jones GT, Williams MJ, McCormick SP.

J Lipid Res. 2015 Jul;56(7):1318-28. doi: 10.1194/jlr.M056150. Epub 2015 Apr 6.

4.

Relationship of oxidized phospholipids on apolipoprotein B-100 to cardiovascular outcomes in patients treated with intensive versus moderate atorvastatin therapy: the TNT trial.

Byun YS, Lee JH, Arsenault BJ, Yang X, Bao W, DeMicco D, Laskey R, Witztum JL, Tsimikas S; TNT Trial Investigators.

J Am Coll Cardiol. 2015 Apr 7;65(13):1286-95. doi: 10.1016/j.jacc.2015.01.050.

PMID:
25835440
5.

Race is a key variable in assigning lipoprotein(a) cutoff values for coronary heart disease risk assessment: the Multi-Ethnic Study of Atherosclerosis.

Guan W, Cao J, Steffen BT, Post WS, Stein JH, Tattersall MC, Kaufman JD, McConnell JP, Hoefner DM, Warnick R, Tsai MY.

Arterioscler Thromb Vasc Biol. 2015 Apr;35(4):996-1001. doi: 10.1161/ATVBAHA.114.304785. Epub 2015 Feb 19.

PMID:
25810300
6.

Mipomersen, an antisense oligonucleotide to apolipoprotein B-100, reduces lipoprotein(a) in various populations with hypercholesterolemia: results of 4 phase III trials.

Santos RD, Raal FJ, Catapano AL, Witztum JL, Steinhagen-Thiessen E, Tsimikas S.

Arterioscler Thromb Vasc Biol. 2015 Mar;35(3):689-99. doi: 10.1161/ATVBAHA.114.304549. Epub 2015 Jan 22.

PMID:
25614280
7.

Oxidation-specific epitopes as targets for biotheranostic applications in humans: biomarkers, molecular imaging and therapeutics.

Miller YI, Tsimikas S.

Curr Opin Lipidol. 2013 Oct;24(5):426-37. doi: 10.1097/MOL.0b013e328364e85a. Review.

8.

Dietary fats and health: dietary recommendations in the context of scientific evidence.

Lawrence GD.

Adv Nutr. 2013 May 1;4(3):294-302. doi: 10.3945/an.113.003657. Review.

9.

Oxidation-specific biomarkers and risk of peripheral artery disease.

Bertoia ML, Pai JK, Lee JH, Taleb A, Joosten MM, Mittleman MA, Yang X, Witztum JL, Rimm EB, Tsimikas S, Mukamal KJ.

J Am Coll Cardiol. 2013 May 28;61(21):2169-79. doi: 10.1016/j.jacc.2013.02.047. Epub 2013 Mar 26.

10.

Acute impact of apheresis on oxidized phospholipids in patients with familial hypercholesterolemia.

Arai K, Orsoni A, Mallat Z, Tedgui A, Witztum JL, Bruckert E, Tselepis AD, Chapman MJ, Tsimikas S.

J Lipid Res. 2012 Aug;53(8):1670-8. doi: 10.1194/jlr.P027235. Epub 2012 May 24.

11.

Oxidized phospholipids on apoB-100-containing lipoproteins: a biomarker predicting cardiovascular disease and cardiovascular events.

Taleb A, Witztum JL, Tsimikas S.

Biomark Med. 2011 Oct;5(5):673-94. doi: 10.2217/bmm.11.60. Review.

12.

High plasma leptin levels confer increased risk of atherosclerosis in women with systemic lupus erythematosus, and are associated with inflammatory oxidised lipids.

McMahon M, Skaggs BJ, Sahakian L, Grossman J, FitzGerald J, Ragavendra N, Charles-Schoeman C, Chernishof M, Gorn A, Witztum JL, Wong WK, Weisman M, Wallace DJ, La Cava A, Hahn BH.

Ann Rheum Dis. 2011 Sep;70(9):1619-24. doi: 10.1136/ard.2010.142737. Epub 2011 Jun 13.

13.

Effects of apple consumption on lipid profile of hyperlipidemic and overweight men.

Vafa MR, Haghighatjoo E, Shidfar F, Afshari S, Gohari MR, Ziaee A.

Int J Prev Med. 2011 Apr;2(2):94-100.

14.

Enigmatic role of lipoprotein(a) in cardiovascular disease.

Anuurad E, Enkhmaa B, Berglund L.

Clin Transl Sci. 2010 Dec;3(6):327-32. doi: 10.1111/j.1752-8062.2010.00238.x.

15.

Changes in lipoprotein(a), oxidized phospholipids, and LDL subclasses with a low-fat high-carbohydrate diet.

Faghihnia N, Tsimikas S, Miller ER, Witztum JL, Krauss RM.

J Lipid Res. 2010 Nov;51(11):3324-30. doi: 10.1194/jlr.M005769. Epub 2010 Aug 16.

16.

Association of Lp-PLA(2) activity with allele-specific Lp(a) levels in a bi-ethnic population.

Enkhmaa B, Anuurad E, Zhang W, Pearson TA, Berglund L.

Atherosclerosis. 2010 Aug;211(2):526-30. doi: 10.1016/j.atherosclerosis.2010.03.021. Epub 2010 Apr 20.

17.

Associations of four circulating chemokines with multiple atherosclerosis phenotypes in a large population-based sample: results from the dallas heart study.

Castillo L, Rohatgi A, Ayers CR, Owens AW, Das SR, Khera A, McGuire DK, de Lemos JA.

J Interferon Cytokine Res. 2010 May;30(5):339-47. doi: 10.1089/jir.2009.0045.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk